GHC Landing

Register Central

It is a unified system for registering medical products (human medicines – medical devices – veterinary medicines) in the GCC Health Council, to ensure the quality, effectiveness and safety of the medical product, and the accuracy of information related to it, and that it is manufactured in accordance with international specifications and standards. It is considered one of the most important goals that the central Gulf committees seek to register medical products to achieve are:

 

Unifying systems and procedures related to the process of registering medical companies and their products in the GCC countries. It also aims to ensure the application of the principles of good manufacturing of medical products, standardize the pricing of drugs marketed in the GCC countries, activate the post-marketing follow-up program for medical products related to quality and side effects of products, which increases integration. And coordination among member states in the field of medical products. The Gulf Products Classification Committee also carries out the classification process based on unified definitions and standards.

Central drug registry goals

It is a unified system for drug registration in the GCC Health Council, to ensure the quality, effectiveness and safety of the drug, and the accuracy of information related to it, and that it is manufactured in accordance with international specifications and standards. This system aims to:

Central Gulf Committee for Drug Registration

It is the committee that was approved to carry out the central drug registration for the countries of the Cooperation Council according to Resolution No. (6) at the forty-fifth conference, which was held in Geneva (Switzerland) in May 1998.

  • Committee members

    Two members from each country

  • Chairmanship of the Committee

    The committee is chaired by one of the member states, and it rotates every year according to the Health Council meetings system

  • Committee meetings

    The committee holds (12) meetings, including (6) meetings that take place via conference call between technicians in the countries to study the registration files in the member states.

The tasks of the committee Central Drug Registry

Approval of pharmaceutical preparation analysis reports issued by accredited reference laboratories in the Member States.

Inspection in the factories of pharmaceutical companies to ensure that the principles of good manufacturing of medicines are applied.

Studying technical reports received from Member States or international bodies on pharmaceutical companies and their preparations and taking the necessary actions in this regard.

Registration of drug and pharmaceutical companies according to the unified registration regulations

Medical Devices and Supplies Registration Committee

It is the committee that works to register medical devices and supplies in accordance with international standards. The committee verifies the safety, effectiveness and efficiency of medical devices.
The committee was formed by a decision of the Ministers in the forty-second session of the Council of Ministers of Health by circulation
The members of the committee study all files related to medical devices and companies’ requests in accordance with the scientific and international foundations in registration. They also constantly develop the registration process according to international amendments and developments in this context. The committee meets six times a year

Registration of medical devices and supplies

It is a unified system for registering medical devices and supplies in the GCC Health Council, whereby a medical device is registered only after ensuring that it has met standards of quality, safety and effectiveness, and the accuracy of information related to it, and that it is manufactured in accordance with international specifications and standards.

Gulf Committee for Pricing of Pharmaceuticals

It is the committee that was approved to do the pricing of pharmaceutical preparations for the GCC countries, according to the following:

  • Committee members

    Two members from each country. The committee is chaired by one of the member states, alternately every year, according to the Health Council meetings system

  • Committee meetings

    The Committee meets regularly throughout the year, approximately every three months, in one of the GCC countries, alternately

Duties of the Gulf Committee for Pricing of Pharmaceuticals

Pricing development

Developing pricing and re-pricing rules for pharmaceutical products and submitting them to higher authorities for approval

Pricing development

Developing pricing and re-pricing rules for pharmaceutical products and submitting them to higher authorities for approval

Repricing

Unifying the prices of centrally and peripherally registered medicines upon re-registration, which takes place every five years in the GCC states and the Health Council (central registration)

Repricing

Unifying the prices of centrally and peripherally registered medicines upon re-registration, which takes place every five years in the GCC states and the Health Council (central registration)

Unify margins

Unifying the profit margin for the agent and the pharmacy between countries, not exceeding 45%

Unify margins

Unifying the profit margin for the agent and the pharmacy between countries, not exceeding 45%

Electronic connectivity

Activating the role of the electronic link between the GCC states in order to quickly obtain and approve information

Electronic connectivity

Activating the role of the electronic link between the GCC states in order to quickly obtain and approve information

Pricing study

Studying topics submitted to the committee by the GCC states related to pricing pharmaceuticals and health products containing vitamins

Pricing study

Studying topics submitted to the committee by the GCC states related to pricing pharmaceuticals and health products containing vitamins

Objection handling

Studying objections raised by pharmaceutical companies and responding to them regarding a price, for many reasons, including transfer of ownership, place of manufacture, or marketer

Objection handling

Studying objections raised by pharmaceutical companies and responding to them regarding a price, for many reasons, including transfer of ownership, place of manufacture, or marketer

Pricing coordination

Unifying systems and pricing procedures in the Gulf countries

Pricing coordination

Unifying systems and pricing procedures in the Gulf countries

Export Unification

Standardizing the export price of innovative medicines registered centrally and peripherally according to therapeutic groups

Export Unification

Standardizing the export price of innovative medicines registered centrally and peripherally according to therapeutic groups

Unified pricing

Unifying the pricing of innovative medicines as a first stage

Unified pricing

Unifying the pricing of innovative medicines as a first stage

Classification of medical and health products

It is the product classification system in the GCC countries. The classification is based on unified definitions and criteria The classification system aims:

Establishing a unified electronic system for product classification in the GCC countries

Standardization of definitions and criteria for classification of products

Classification of products centrally at the level of the Gulf Cooperation Council countries